Cytokinetics
CYTK
CYTK
134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
38% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $1.99M
45% less capital invested
Capital invested by funds: $575M → $315M (-$261M)
Holders
134
Holding in Top 10
1
Calls
$1.24M
Puts
$1.99M
Top Buyers
| 1 | +$36.5M | |
| 2 | +$7.96M | |
| 3 | +$7.18M | |
| 4 |
BlackRock
New York
|
+$3.21M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.85M |
Top Sellers
| 1 | -$40.3M | |
| 2 | -$17.7M | |
| 3 | -$6.75M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.43M |